PureTech Health (PRTC)
(Delayed Data from NSDQ)
$28.68 USD
+0.17 (0.60%)
Updated May 16, 2024 12:04 PM ET
After-Market: $29.25 +0.57 (1.98%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (86 out of 248)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | NA | 2.87 | 57.00 |
Year Ago Quarter Estimate | NA | -5.36 | 52.54 |
Next Quarter Estimate | NA | 7.43 | 61.00 |
Next Year Estimate | -5.17 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -1,037.50 | 14.60 | 15.67 |
Next Year | -89.38 | 7.90 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.69 | 2.10 |
Price/Cash Flow (MRFY) | NA | 16.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -88.73% |
Return on Equity (TTM) | NA | -44.24% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.